Leaderboards/ai in cancer detection

ai in cancer detection

Last updated June 2, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Nora Eisemann
University of Lübeck
99
2
Alexander Katalinic
University of Lübeck
90
3
Frank Christiansen
Science for Life Laboratory
80
4
E. Epstein
Karolinska Institutet
70
5
Dyke Ferber
Heidelberg University
60
6
Mattie Salim
Karolinska University Hospital
40
7
Fredrik Strand
Karolinska University Hospital
30

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
A.Y. Ng
Kheiron Medical Technologies (United Kingdom)
99
2
Kristina Lång
Lund University
90
3
Charlie Saillard
International Office for Water
80
4
Karin Dembrower
Karolinska Institutet
70
5
Michael H. Bernstein
Brown University
60
6
Vibhas Chugh
Institute of Nano Science and Technology
50
7
Mengdi Han
Beijing Institute of Petrochemical Technology
40
8
Naglaa F. Noaman
Xidian University
20
9
T R Mahesh
Jain University
10

Emerging Leaders Papers

Insufficient data

All-Time Leaders

The canon

All-Time Leaders Researchers

1
M. Castiglione
Instituut Verbeeten
99
2
Nicholas C. Turner
Institute of Cancer Research
90
3
Alexander Katalinic
University of Lübeck
80
4
Martin C. Stumpe
Google (United States)
70
5
Peter D. Kecskemethy
Kheiron Medical Technologies (United Kingdom)
60
6
Fredrik Strand
Karolinska University Hospital
50
7
Xiaogang Liu
Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
40
8
Ioannis Sechopoulos
Unknown
30
9
Lora Aroyo
Google (United States)
20
10
Ritse M. Mann
Radboud University Nijmegen
10

All-Time Leaders Papers

1
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
New England Journal of Medicine|2018
1.3k cit.
2
Breast MRI: guidelines from the European Society of Breast Imaging
European Radiology|2008
819 cit.
3
ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group
Annals of Oncology|2022
633 cit.
4
A Marker of Homologous Recombination Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Primary Breast Cancer
Clinical Cancer Research|2010
323 cit.
5
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer
Nature Communications|2020
258 cit.
6
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer
Annals of Oncology|2022
184 cit.
7
Inactivating <i>NF1</i> Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance
Clinical Cancer Research|2019
136 cit.
8
<i>ESR1</i> F404 Mutations and Acquired Resistance to Fulvestrant in <i>ESR1</i> -Mutant Breast Cancer
Cancer Discovery|2023
35 cit.
9
Inhibition of GPX4 enhances CDK4/6 inhibitor and endocrine therapy activity in breast cancer
Nature Communications|2024
28 cit.
10
Ants work harder during consensus decision-making in small groups
Journal of The Royal Society Interface|2014
22 cit.

Indexing ai in cancer detection Reagents

Citation data for reagents in this field is currently compiling.